Ticker > Company >

Sanjivani Paranteral share price

Sanjivani Paranteral Ltd.

BSE: 531569 SECTOR: Pharmaceuticals & Drugs  16k   19   0

289.85
0 0
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 289.85

Today's Low

₹ 278.55

52 Week High

₹ 347

52 Week Low

₹ 122.15

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

338.67 Cr.

Enterprise Value

330.07 Cr.

No. of Shares

1.17 Cr.

P/E

48.95

P/B

10.61

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  27.31

CASH

9.56 Cr.

DEBT

0.97 Cr.

Promoter Holding

27.67 %

EPS (TTM)

₹  5.92

Sales Growth

53.31%

ROE

54.08 %

ROCE

55.32%

Profit Growth

36.65 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year53.31%
3 Year29.42%
5 Year16.74%

Profit Growth

1 Year36.65%
3 Year63.16%
5 Year37.88%

ROE%

1 Year54.08%
3 Year18.03%
5 Year10.82%

ROCE %

1 Year55.32%
3 Year18.44%
5 Year11.16%

Debt/Equity

0.0375

Price to Cash Flow

-31.64

Interest Cover Ratio

30.865

CFO/PAT (5 Yr. Avg.)

0.190964003325658

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 27.67 0.00
Jun 2024 27.67 0.00
Mar 2024 27.67 0.00
Dec 2023 32.34 0.00
Sep 2023 32.34 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 63.1634262809065% for the Past 3 years.
  • The company has shown a good revenue growth of 29.4205084119051% for the Past 3 years.
  • The company has significantly decreased its debt by 1.5243704 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 30.865.
  • The company has an efficient Cash Conversion Cycle of -55.0319 days.
  • Company has a healthy liquidity position with current ratio of 2.0783.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.89074552916942.

 Limitations

  • Company has negative cash flow from operations of -10.7033661.
  • The company is trading at a high EV/EBITDA of 33.1145.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 14 14.96 12.86 16.44 18.13
Total Expenditure 11.89 13 10.71 14.1 15.28
Operating Profit 2.11 1.96 2.16 2.34 2.85
Other Income 0.15 0.25 0.05 0.09 0.39
Interest 0.05 0.08 0.09 0.02 0.18
Depreciation 0.23 0.24 0.24 0.13 0.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.99 1.9 1.89 2.27 2.92
Tax 0.28 0.25 0.63 0.56 0.62
Profit After Tax 1.71 1.65 1.26 1.71 2.3
Adjusted EPS (Rs) 1.71 1.65 1.08 1.47 1.97

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 16.36 25.1 30.61 35.49 54.41
Total Expenditure 16.91 22.96 26.36 30.24 46.4
Operating Profit -0.55 2.14 4.25 5.25 8.02
Other Income 0.47 0.26 1.72 0.94 0.74
Interest 0.66 0.13 0.21 0.36 0.25
Depreciation 1.07 0.86 0.88 0.89 0.93
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.81 1.41 4.88 4.94 7.57
Tax -0.1 -0.01 0.03 0.43 1.41
Net Profit -1.71 1.42 4.85 4.51 6.17
Adjusted EPS (Rs.) -2.9 1.67 4.85 4.51 5.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.9 8.5 10 10 11.68
Total Reserves -54.81 -53.39 -17.58 -13.07 16.21
Borrowings 7.95 5.3 2.75 0.76 0.97
Other N/C liabilities 1.22 1.24 1.24 0.67 0.76
Current liabilities 55.4 57.63 21.89 22.65 13.78
Total Liabilities 15.66 19.28 18.3 21.01 43.41
Assets
Net Block 8.04 7.62 7.42 7.57 9.94
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.05 0.05 0
Loans & Advances 3.72 2.38 3.1 5.11 4.81
Other N/C Assets 0.05 0.05 0 0.01 0.01
Current Assets 3.79 9.18 7.73 8.27 28.64
Total Assets 15.66 19.28 18.3 21.01 43.41
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -1.81 1.41 4.88 4.94 7.57
Adjustment 1.56 1.36 -0.52 0.68 0.77
Changes in Assets & Liabilities 0.08 -2.16 4.22 -0.9 -17.93
Tax Paid -0.01 -0.03 -0.05 -0.04 -1.11
Operating Cash Flow -0.17 0.58 8.52 4.68 -10.7
Investing Cash Flow -0.12 -0.42 -0.67 -0.99 -12.21
Financing Cash Flow 0.33 -0.26 -7.68 -3.73 23.16
Net Cash Flow 0.03 -0.09 0.17 -0.04 0.24

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 32.34 32.34 27.67 27.67 27.67
ashwani khemka 30.26 30.26 25.90 25.90 25.90
naina khemka 2.07 2.07 1.78 1.78 1.78
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 67.66 67.66 72.33 72.33 72.33
ashish kacholia - - 3.17 3.17 3.17
india equity fund 1 - - 5.14 5.14 5.14
kanta suresh jain . - - 7.17 7.04 6.57
monika garware - - 2.57 2.57 2.57
next orbit ventures fund 8.16 6.01 4.57 4.22 1.12
sun capital advisory serv... 5.00 5.00 4.28 4.28 4.28
suresh pukhraj jain . - - 7.17 - 6.76
usha ravindra bhat 2.70 2.05 2.00 2.00 2.00
suresh pukhraj jain 8.15 8.00 - 6.79 -
llp 0.10 0.40 0.94 - -
kanta suresh jain 7.41 8.00 - - -
rajesh chimanlal jogani... - 1.08 - - -
setu securities private l... - 1.28 - - -
surekha haran 1.01 - - - -

Ratings & Research Reports

Company Presentations

Company News

Sanjivani Paranteral - Quaterly Results 28 Oct, 4:41 PM Sanjivani Paranteral - Quaterly Results 28 Oct, 4:41 PM Sanjivani Paranteral informs about conference call 24 Oct, 5:30 PM Sanjivani Parantera informs about board meeting 4 Sep, 5:29 PM Sanjivani Paranteral informs about appointment of CS cum CO 17 Aug, 2:10 PM Sanjivani Paranteral - Quaterly Results 6 Aug, 1:51 PM Sanjivani Paranteral - Quaterly Results 6 Aug, 1:51 PM Sanjivani Paranteral - Quaterly Results 6 Aug, 1:51 PM Sanjivani Paranteral informs about conference call 3 Aug, 2:38 PM Sanjivani Paranteral submits investor presentation 9 Jul, 2:36 PM Sanjivani Paranteral - Quaterly Results 13 May, 7:38 PM Sanjivani Paranteral - Quaterly Results 13 May, 7:38 PM Sanjivani Paranteral informs about outcome of board meeting 8 Apr, 3:16 PM Sanjivani Paranteral incorporates subsidiary company 28 Feb, 6:33 PM Sanjivani Paranteral informs about audio recording of investors meet 13 Feb, 11:38 AM Sanjivani Paranteral informs about press release 12 Feb, 1:10 PM Sanjivani Paranteral informs about investor presentation 12 Feb, 1:04 PM Sanjivani Paranteral - Quaterly Results 5 Feb, 1:44 PM Sanjivani Paranteral - Quaterly Results 5 Feb, 1:44 PM Sanjivani Paranteral - Quaterly Results 5 Feb, 1:44 PM Sanjivani Paranteral informs about EGM outcome 18 Jan, 3:27 PM Sanjivani Paranteral informs about compliances-certificate 10 Jan, 1:21 PM Sanjivani Paranteral informs about press release 26 Dec, 4:41 PM Sanjivani Paranteral informs about closure of trading window 19 Dec, 1:45 PM Sanjivani Paranteral informs about revised investor presentation 22 Nov, 12:19 PM Sanjivani Paranteral informs about newspaper publication 23 Oct, 12:19 PM Sanjivani Paranteral informs about investor presentation 19 Oct, 12:36 PM Sanjivani Paranteral informs about revised press release 19 Oct, 10:49 AM Sanjivani Paranteral - Quaterly Results 18 Oct, 2:44 PM Sanjivani Paranteral - Quaterly Results 18 Oct, 2:44 PM Sanjivani Paranteral - Quaterly Results 18 Oct, 2:44 PM Sanjivani Paranteral inks pact with Hindustan Antibiotics 2 Aug, 3:15 PM Sanjivani Paranteral informs about outcome of board meeting 24 Jul, 4:17 PM Sanjivani Paranteral - Quaterly Results 24 Jul, 3:15 PM Sanjivani Paranteral - Quaterly Results 24 Jul, 3:15 PM Sanjivani Paranteral - Quaterly Results 24 Jul, 3:15 PM Sanjivani Paranteral informs about certificate 11 Jul, 1:02 PM Sanjivani Paranteral informs about disclosure 19 Jun, 1:48 PM Sanjivani Paranteral informs about disclosure 17 Jun, 3:10 PM Sanjivani Paranteral informs about disclosure 8 Jun, 12:20 PM Sanjivani Paranteral informs about newspaper publication 9 May, 5:21 PM Sanjivani Paranteral enters into partnership with Aievia Helathcare 9 May, 3:49 PM Sanjivani Paranteral informs about outcome of board meeting 6 May, 2:33 PM Sanjivani Paranteral - Quaterly Results 6 May, 1:44 PM Sanjivani Paranteral - Quaterly Results 6 May, 1:44 PM Sanjivani Paranteral - Quaterly Results 6 May, 1:44 PM Sanjivani Paranteral informs about disclosure 1 Apr, 1:01 PM Sanjivani Paranteral informs about disclosure 27 Mar, 4:29 PM Sanjivani Paranteral informs about disclosure 14 Mar, 3:01 PM Sanjivani Paranteral - Quaterly Results 14 Feb, 12:47 PM

Sanjivani Paranteral Stock Price Analysis and Quick Research Report. Is Sanjivani Paranteral an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sanjivani Paranteral and its performance over the period of time. Sanjivani Paranteral stock price today is Rs 289.85.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sanjivani Paranteral cash from the operating activity was Rs -10.7033661 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sanjivani Paranteral has a Debt to Equity ratio of 0.0375 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sanjivani Paranteral , the EPS growth was 16.9337 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sanjivani Paranteral has OPM of 14.731237637387 % which is a bad sign for profitability.
     
  • ROE: Sanjivani Paranteral have a healthy ROE of 54.0784 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sanjivani Paranteral is Rs 289.85. One can use valuation calculators of ticker to know if Sanjivani Paranteral share price is undervalued or overvalued.
Last Updated on:
Brief about Sanjivani Paranteral
X